Procter & Gamble Hygiene and Health Care Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Lalgudi Vaidyanathan

Chief executive officer

₹21.4m

Total compensation

CEO salary percentage	100.0%
CEO tenure	1.8yrs
CEO ownership	n/a
Management average tenure	2.2yrs
Board average tenure	4.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Lalgudi Vaidyanathan's remuneration changed compared to Procter & Gamble Hygiene and Health Care's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	₹8b
Sep 30 2023	n/a	n/a	₹7b
Jun 30 2023	₹21m	₹21m	₹7b

Compensation vs Market: Lalgudi's total compensation ($USD257.09K) is below average for companies of similar size in the Indian market ($USD599.06K).

Compensation vs Earnings: Insufficient data to compare Lalgudi's compensation with company performance.

CEO

Lalgudi Vaidyanathan

1.8yrs

Tenure

₹21,435,006

Compensation

Mr. Lalgudi Viswanathan Vaidyanathan is Chief Executive Officer of Operations in India of The Procter & Gamble Company from July 01, 2022. He is MD & Director of Procter & Gamble Hygiene and Health Care Li...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Lalgudi Vaidyanathan	MD & Director	1.8yrs	₹21.44m	no data
Prashant Bhatnagar	Chief Financial Officer	9.5yrs	₹11.52m	no data
Ghanashyam Hegde	Legal Head	2.6yrs	₹10.88m	no data
John Chevalier	Chief Investor Relations Officer	7.9yrs	no data	no data
Enakshee Deva	Head of Communications & CSR	no data	no data	no data
Mukta Maheshwari	Chief Marketing Officer	less than a year	no data	no data
Sairamana Ponugoti	Sales Head	no data	no data	no data
P. Srinivas	Head of Human Resource	no data	no data	no data
Madhusudan Gopalan	Senior Vice President of Grooming & Oral Care and P&G Japan & Korea	1.8yrs	₹52.51m	no data
Gautam Kamath	Finance Head	no data	no data	no data
Pawan Verma	Purchases Head	no data	no data	no data
Sachan Saini	Government Relations Head	no data	no data	no data

2.2yrs

Average Tenure

45yo

Average Age

Experienced Management: 500459's management team is considered experienced (2.2 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Lalgudi Vaidyanathan	MD & Director	1.8yrs	₹21.44m	no data
Ghanashyam Hegde	Legal Head	4.9yrs	₹10.88m	no data
Gurcharan C. Das	Non-Executive Independent Director	1.6yrs	₹1.63m	no data
Anil Kumar Ishwar Gupta	Non-Executive Independent Director	11.3yrs	₹2.60m	no data
Chittranjan Dua	Non-Executive Independent Chairman	3.7yrs	₹2.30m	no data
Pramod Agarwal	Non-Executive Director	8.9yrs	₹2.00m	0.00015% ₹ 785.0k
Ashima Goyal	Independent Non-Executive Director	less than a year	no data	no data
Sonali Dhawan	Non-Executive Director	9.9yrs	no data	no data
Krishnamurthy Iyer	Non-Executive Independent Director	3.3yrs	₹2.05m	no data
Gagan Sawhney	Non-Executive Director	5.3yrs	no data	no data

4.3yrs

Average Tenure

64.5yo

Average Age

Experienced Board: 500459's board of directors are considered experienced (4.3 years average tenure).

Procter & Gamble Hygiene and Health Care Management

Management criteria checks 3/4

Key information

Recent management updates

Less than half of directors are independent

Procter & Gamble Hygiene and Health Care Limited Announces Resignation of Karthik Natarajan as Non- Executive Director, Effective from Close of Business Hours of March 31, 2024

Procter & Gamble Hygiene and Health Care Limited, Annual General Meeting, Nov 24, 2023

Procter & Gamble Hygiene and Health Care Limited Announces Change in Management

Less than half of directors are independent

Procter & Gamble Hygiene and Health Care Limited, Annual General Meeting, Nov 15, 2022

Recent updates

Procter & Gamble Hygiene and Health Care Limited to Report Q3, 2024 Results on Apr 30, 2024

Less than half of directors are independent

Second quarter 2024 earnings released: EPS: ₹70.51 (vs ₹63.91 in 2Q 2023)

Procter & Gamble Hygiene and Health Care Limited Announces Resignation of Karthik Natarajan as Non- Executive Director, Effective from Close of Business Hours of March 31, 2024

Procter & Gamble Hygiene and Health Care Limited to Report Q2, 2024 Results on Jan 31, 2024

Upcoming dividend of ₹105 per share at 1.0% yield

Procter & Gamble Hygiene and Health Care Limited, Annual General Meeting, Nov 24, 2023

First quarter 2024 earnings released: EPS: ₹64.91 (vs ₹47.57 in 1Q 2023)

Procter & Gamble Hygiene and Health Care Limited to Report Q1, 2024 Results on Oct 30, 2023

Price target increased by 9.2% to ₹16,940

Procter & Gamble Hygiene and Health Care Limited Announces Change in Management

Full year 2023 earnings released: EPS: ₹209 (vs ₹177 in FY 2022)

Procter & Gamble Hygiene and Health Care Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

Third quarter 2023 earnings released: EPS: ₹50.84 (vs ₹31.68 in 3Q 2022)

Procter & Gamble Hygiene and Health Care Limited Approves Dividend for the Financial Year 2022-23, Payable on or Before February 28, 2023

Second quarter 2023 earnings released: EPS: ₹63.91 (vs ₹65.33 in 2Q 2022)

Procter & Gamble Hygiene and Health Care Limited to Report Q2, 2023 Results on Jan 31, 2023

Price target decreased to ₹14,250

Less than half of directors are independent

Price target decreased to ₹14,250

Upcoming dividend of ₹65.00 per share

Full year 2022 earnings released: EPS: ₹177 (vs ₹201 in FY 2021)

Procter & Gamble Hygiene and Health Care Limited to Report Q1, 2023 Results on Nov 02, 2022

Procter & Gamble Hygiene and Health Care Limited, Annual General Meeting, Nov 15, 2022

Procter & Gamble Hygiene and Health Care Limited Recommends Final Dividend for the Financial Year Ended June 30, 2022, Payable Between November 15, 2022 to December 13, 2022

Price target decreased to ₹15,850

Third quarter 2022 earnings released: EPS: ₹31.68 (vs ₹30.29 in 3Q 2021)

Less than half of directors are independent

Procter & Gamble Announces Appointment of LV Vaidyanathan as Chief Executive Officer for its Operations in India from July 1, 2022 Replacing Madhusudan Gopalan

Procter & Gamble Hygiene and Health Care Limited to Report Q3, 2022 Results on Apr 28, 2022

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Procter & Gamble Hygiene and Health Care Limited Declares Interim Dividend for the Financial Year 2022, Payable on or Before February 28, 2022

Price target increased to ₹17,450

Upcoming dividend of ₹80.00 per share

Full year 2021 earnings released: EPS ₹201 (vs ₹133 in FY 2020)

Company Secretary & Compliance Officer Flavia Machado has left the company

Full year 2021 earnings released: EPS ₹201 (vs ₹133 in FY 2020)

Third quarter 2021 earnings released: EPS ₹30.29 (vs ₹28.07 in 3Q 2020)

Procter & Gamble Hygiene and Health Care Limited Declares Special Interim Dividend for the Financial Year 2021, Payable Between May 25, 2021 to June 2, 2021

Price target increased to ₹15,900

Second quarter 2021 earnings released: EPS ₹77.21 (vs ₹41.88 in 2Q 2020)

New 90-day high: ₹12,289

Procter & Gamble Hygiene and Health Care Limited to Report Q2, 2021 Results on Feb 03, 2021

New 90-day high: ₹11,409

First quarter 2021 earnings released: EPS ₹78.21

Price target raised to ₹11,700

Full year 2020 earnings released: EPS ₹133

Procter & Gamble Hygiene and Health Care Limited to Report Q1, 2021 Results on Nov 10, 2020

P&G-owned skincare brand Olay Teams Up with Shopee to Empower Digital-Savvy Millennials in Southeast Asia to #AdultFearlessly

New 90-day low: ₹9,862

Procter & Gamble Hygiene and Health Care Limited(BSE:500459) dropped from S&P Global BMI Index

Full year earnings released - EPS ₹133

Procter & Gamble Hygiene and Health Care Limited to Report Fiscal Year 2020 Results on Aug 25, 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age